Skip to main navigation Skip to search Skip to main content

Action of Reverse T3 on Cancer Cells

  • Hung Yun Lin
  • , Heng Yuan Tang
  • , Matthew Leinung
  • , Shaker A. Mousa
  • , Aleck Hercbergs
  • , Paul J. Davis

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Reverse T3 (rT3; 3,3',5'-triiodo-L-thyronine) is widely regarded as an inactive naturally occurring analog of thyroid hormone. rT3 is known to bind to the thyroid hormone analog receptor on plasma membrane integrin αvβ3. This integrin is generously expressed by tumor cells and is the initiation site for the stimulation by L-thyroxine (T4) at physiological free concentrations on cancer cell proliferation. Results: In the present studies, we show that rT3 caused increases of proliferation in vitro of 50% to 80% (P < 0.05–0.001) of human breast cancer and glioblastoma cells. Conclusion: rT3 may be a host factor supporting cancer growth.

Original languageEnglish
Pages (from-to)148-152
Number of pages5
JournalEndocrine Research
Volume44
Issue number4
DOIs
Publication statusPublished - Jan 1 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • 3,3',5’-triiodo-L-thyronine
  • breast cancer
  • glioblastoma
  • Integrin αvβ3
  • L-thyroxine

ASJC Scopus subject areas

  • Endocrinology

Fingerprint

Dive into the research topics of 'Action of Reverse T3 on Cancer Cells'. Together they form a unique fingerprint.

Cite this